Ixekizumab Significantly Improves Self-reported Overall Health as Measured by Short-Form-36 in Patients with Active Non-radiographic Axial Spondyloarthritis: 16-and 52-Week Results of a Phase 3 Randomized Trial (COAST-X)

被引：0
|
作者：
Walsh, Jessica [1 ]
Magrey, Marina [2 ,3 ]
Kiltz, Uta [4 ]
Baraliakos, Xenofon [4 ]
Weng, Maggie [5 ]
Hunter, Theresa [6 ]
Li, Xiaoqi [6 ]
Leon, Luis [6 ]
Sandoval, David [6 ]
Inui, Kentaro [7 ]
机构：
[1] Univ Utah, Div Rheumatol, Salt Lake City, UT USA
[2] MetroHlth Syst, Div Rheumatol, Cleveland, OH USA
[3] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[4] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany
[5] Natl Cheng Kung Univ, Med Ctr, Tainan, Taiwan
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Osaka City Univ, Grad Sch Med, Dept Orthopaed Surg, Osaka, Japan
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1545
引用
收藏
页数：3
相关论文
共 18 条
  • [1] IXEKIZUMAB IMPROVES SELF-REPORTED OVERALL FUNCTIONING AND HEALTH AS MEASURED BY THE ASAS HEALTH INDEX IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL (COAST-X)
    Kiltz, U.
    Walsh, J. A.
    Vargas, R. B.
    Hunter, T.
    Bolce, R.
    Sandoval, D.
    Leage, S. Liu
    Leung, A.
    Li, X.
    Blue, E.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 722 - 722
  • [2] Ixekizumab Improves Self-reported Overall Functioning and Health as Measured by the Assessment of SpondyloArthritis International Society Health Index in Patients with Active Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Randomized Trials
    Kiltz, Uta
    van der Heijde, Desiree
    Boonen, Annelies
    Gensler, Lianne
    Hunter, Theresa
    Zhao, Fangyi
    Zhu, Baojin
    Bolce, Rebecca
    Carlier, Hilde
    Braun, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [3] IXEKIZUMAB SIGNIFICANTLY IMPROVES SELF-REPORTED OVERALL HEALTH AS MEASURED BY SF-36 IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS NAIVE TO BIOLOGICAL THERAPY: 52 WEEK RESULTS OF A PHASE 3 TRIAL
    Wei, James Cheng-Chung
    van den Bosch, Filip
    Walsh, Jessica A.
    Kiltz, Uta
    Hunter, Theresa
    Dong, Yan
    Leung, Ann
    Sandoval, David
    Leon, Luis
    Strand, Vibeke
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1817 - 1818
  • [4] Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
    Deodhar, Atul
    Mease, Philip
    Rahman, Proton
    Navarro-Compan, Victoria
    Marzo-Ortega, Helena
    Hunter, Theresa
    Sandoval, David
    Kronbergs, Andris
    Leon, Luis
    Shan, Mingyang
    Leung, Ann
    De Vlam, Kurt
    Strand, Vibeke
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 135 - 150
  • [5] Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
    Atul Deodhar
    Philip Mease
    Proton Rahman
    Victoria Navarro-Compán
    Helena Marzo-Ortega
    Theresa Hunter
    David Sandoval
    Andris Kronbergs
    Luis Leon
    Mingyang Shan
    Ann Leung
    Kurt De Vlam
    Vibeke Strand
    Rheumatology and Therapy, 2021, 8 : 135 - 150
  • [6] Ixekizumab Significantly Improves Patient-reported Overall Health as Measured by SF-36 in Patients with Active Ankylosing Spondylitis/Radiographic Axial Spondyloarthritis: 52-Week Results of Two Phase 3 Trials
    Wei, Cheng-Chung
    Hunter, Theresa
    Van den Bosch, Filip
    Walsh, Jessica
    Kiltz, Uta
    Dong, Yan
    Sandoval, David
    Leon, Luis
    Strand, Vibeke
    Li, Xiaoqi
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [7] Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
    Deodhar, Atul
    Mease, Philip
    Marzo-Ortega, Helena
    Hunter, Theresa
    Sandoval, David
    Kronbergs, Andris
    Lauzon, Steven
    Leung, Ann
    Navarro-Compan, Victoria
    BMC RHEUMATOLOGY, 2021, 5 (01)
  • [8] Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
    Atul Deodhar
    Philip Mease
    Helena Marzo-Ortega
    Theresa Hunter
    David Sandoval
    Andris Kronbergs
    Steven Lauzon
    Ann Leung
    Victoria Navarro-Compán
    BMC Rheumatology, 5
  • [9] IMPACT OF IXEKIZUMAB ON WORK PRODUCTIVITY IN NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS PATIENTS: RESULTS FROM THE COAST-X TRIAL AT 52 WEEKS
    Deodhar, A.
    Mease, P. J.
    Gensler, L. S.
    Rahman, P.
    Navarro-Compan, V.
    Marzo-Ortega, H.
    Hunter, T.
    Sandoval, D.
    Kronbergs, A.
    Zhu, B.
    Leung, A.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 422 - 422
  • [10] Impact of Ixekizumab on Work Productivity in Non-Radiographic Axial Spondyloarthritis Patients: Results from the COAST-X Trial at 52 Weeks
    Deodhar, Atul
    Mease, Philip
    Gensler, Lianne
    Rahman, Proton
    Navarro-Compan, Victoria
    Marzo-Ortega, Helena
    Hunter, Theresa
    Sandoval, David
    Kronbergs, Andris
    Zhu, Baojin
    Leung, Ann
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12